TEVA adds $1.65 to $52.85 and options volume is 3.5X the average daily, being led by a buyer of 8,000 Mar 55 calls at $1.20 on ISE. Sentiment data indicate a customer opened a new position. 11,130 traded. Jan 50, 52.5 and 55 calls are seeing interest as well. The Jan 50 is the most actively traded put. 37,000 calls and 14,000 puts now traded in the pharmaceutical maker and implied volatility is up 24 percent to 25. Shares fell early, but then saw a spike on news the FDA issued a response letter for TEVA’s glatiramer acetate snda. The FDA could not approve app as submitted, but TEVA intends to continue working closely with FDA to determine the next steps to take with respect to the application.